Antihypertensive Agents - Research News and Information

Wednesday, January 07, 2009

Ginsenosides chemistry, biosynthesis, analysis, and potential health effects.

30 Dec 2008 Ginsenosides are a special group of triterpenoid saponins that can be classified into two groups by the skeleton of their aglycones, namely dammarane- and oleanane-type. Ginsenosides are found nearly exclusively in Panax species (ginseng) and up to ... Read more...

Sexual dysfunction: the 'prima ballerina' of hypertension-related quality-of-life complications.

30 Oct 2008 Sexual dysfunction is currently considered a serious quality-of-life-related health problem, exerting a major impact on patients' and their sexual partners' life. Available data indicate that essential hypertension is a risk factor for sexual ... Read more...

The Anglo-Scandinavian Cardiac Outcomes Trial: blood pressure-lowering limb: effects in patients with type II diabetes.

30 Oct 2008 OBJECTIVE: To compare the effects of two antihypertensive treatment strategies for the prevention of coronary heart disease and other cardiovascular events in the large subpopulation (n=5137) with diabetes mellitus in the blood pressure-lowering ... Read more...

Learn Faster Today      Improve your study skills

Latest indexed articles for 'Antihypertensive Agents'

These are the very latest articles for this heading:

• Ginsenosides chemistry, biosynthesis, analysis, and potential health effects. 30 Dec 2008
• Sexual dysfunction: the 'prima ballerina' of hypertension-related quality-of-life complications. 30 Oct 2008
• The Anglo-Scandinavian Cardiac Outcomes Trial: blood pressure-lowering limb: effects in patients with type II diabetes. 30 Oct 2008
• Do psychological attributes matter for adherence to antihypertensive medication? The Finnish Public Sector Cohort Study. 30 Oct 2008
• Effects of oxidative stress in trabecular meshwork cells are reduced by prostaglandin analogues. 30 Oct 2008
• Summaries for patients. A combination treatment for pulmonary hypertension. 19 Oct 2008
• Addition of sildenafil to long-term intravenous epoprostenol therapy in patients with pulmonary arterial hypertension: a randomized trial. 19 Oct 2008
• Therapy for pulmonary arterial hypertension: the more, the merrier? 19 Oct 2008
• Metabolic syndrome affects cardiovascular risk profile and response to treatment in hypertensive postmenopausal women. 11 Oct 2008
• UKPDS and the legacy effect. 7 Oct 2008
• [Antihypertensive treatment preceding cerebrovascular diseases is insufficient according to recommendations] 4 Oct 2008
• Effect of prazosin on dynamic cerebral autoregulation during acute hypotension in healthy human subjects. 30 Sep 2008
• Intensive glucose control in type 2 diabetes. 30 Sep 2008
• Rapid metabolite identification with sub parts-per-million mass accuracy from biological matrices by direct infusion nanoelectrospray ionization after clean-up on a ZipTip and LTQ/Orbitrap mass spectrometry. 29 Sep 2008
• Structure and characterization of human carboxylesterase 1A1, 1A2, and 1A3 genes. 29 Sep 2008
• Is fixed severe pulmonary hypertension still a contraindication to heart transplant in the modern era of mechanical circulatory support? A review. 29 Sep 2008
• The ECLIPSE trials: comparative studies of clevidipine to nitroglycerin, sodium nitroprusside, and nicardipine for acute hypertension treatment in cardiac surgery patients. 29 Sep 2008
• Prognostic value of the insertion/deletion polymorphism of the ACE gene in type 2 diabetic subjects: results from the Non-Insulin-Dependent Diabetes, Hypertension, Microalbuminuria or Proteinuria, Cardiovascular events, and Ramipril (DIABHYCAR), Diabete de type 2, Nephropathie et Genetique (DIAB2NEPHROGENE), and Survie, Diabete de type 2 et Genetique (SURDIAGENE) studies: response to Hadjadj et al. 29 Sep 2008
• Development of novel fast-disintegrating tablets by direct compression using sucrose stearic acid ester as a disintegration-accelerating agent. 29 Sep 2008
• Evaluation of drug-drug interaction potential of beraprost sodium mediated by P450 in vitro. 29 Sep 2008

See a longer list of these articles.

Technical information about 'Antihypertensive Agents'

Definition: Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS.

Registry Number: 0

Descriptor UI: D000959

Alternative terms: Antihypertensive Agents; Agents, Antihypertensive; Antihypertensives; Anti-Hypertensives; Anti Hypertensives; Antihypertensive Drugs; Drugs, Antihypertensive; Anti-Hypertensive Agents; Agents, Anti-Hypertensive; Anti Hypertensive Agents; Anti-Hypertensive Drugs; Anti Hypertensive Drugs; Drugs, Anti-Hypertensive;

Related Mesh Headings: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Diuretics; Ganglionic Blockers; Vasodilator Agents;

Allowable Qualifiers: administration & dosage; adverse effects; analysis; antagonists & inhibitors; blood; cerebrospinal fluid; chemical synthesis; classification; diagnostic use; economics; history; immunology; isolation & purification; metabolism; pharmacokinetics; pharmacology; poisoning; radiation effects; standards; supply & distribution; therapeutic use; toxicity; urine; chemistry; contraindications; agonists;

Tree Number: D27.505.954.411.162;

Technical Notes: not for ocular hypertension